Mr Hawkins spent the past seven years in founder and leadership roles developing and commercializing medical devices for incubators funded by Three Arch Partners, Frazier Healthcare, Prospect Ventures, MPM Capital and Charter Ventures.
John McDermott, president and CEO of Endologix, said: “Daniel brings a successful track record of developing and launching new medical technologies. He is a results-oriented leader with wide-breadth experience who will strengthen our senior management team and drive our new product development portfolio and business development activities.
“Daniel also has a strong commercial background that will be instrumental in achieving continued market share gains and support the successful commercialization of our Powerlink XL, our suprarenal proximal extensions and the recently introduced IntuiTrak delivery system.”